Literature DB >> 33510354

Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR.

Bosen You1,2,3, Yin Sun3, Jie Luo3, Keliang Wang1,3, Qing Liu2,3, Ruizhe Fang1,3, Bingmei Liu4, Fuju Chou3, Ronghao Wang3, Jialin Meng3, Chi-Ping Huang5, Shuyuan Yeh3, Chawnshang Chang6,7, Wanhai Xu8.   

Abstract

While the androgen receptor (AR) may influence the progression of clear cell renal cell carcinoma (ccRCC), its role to impact vasculogenic mimicry (VM) to alter the ccRCC progression and metastasis remains obscure. Here, we demonstrated that elevated AR expression was positively correlated with tumor-originated vasculogenesis in ccRCC patients. Consistently, in vitro research revealed AR promoted VM formation in ccRCC cell lines via modulating lncRNA-TANAR/TWIST1 signals. Mechanism dissection showed that AR could increase lncRNA-TANAR (TANAR) expression through binding to the androgen response elements (AREs) located in its promoter region. Moreover, we found that TANAR could impede nonsense-mediated mRNA decay (NMD) of TWIST1 mRNA by direct interaction with TWIST1 5'UTR. A preclinical study using in vivo mouse model with orthotopic xenografts of ccRCC cells further confirmed the in vitro data. Together, these results illustrated that AR-mediated TANAR signals might play a crucial role in ccRCC VM formation and metastasis, and targeting this newly identified AR/TANAR/TWIST1 signaling may help in the development of a novel anti-angiogenesis therapy to better suppress the ccRCC progression.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33510354      PMCID: PMC7932923          DOI: 10.1038/s41388-020-01616-1

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  53 in total

Review 1.  Gender differences in incidence and outcomes of urothelial and kidney cancer.

Authors:  Ilaria Lucca; Tobias Klatte; Harun Fajkovic; Michela de Martino; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2015-10       Impact factor: 14.432

2.  Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma.

Authors:  Remi Adelaiye-Ogala; Nur P Damayanti; Ashley R Orillion; Sreevani Arisa; Sreenivasulu Chintala; Mark A Titus; Chinghai Kao; Roberto Pili
Journal:  Cancer Res       Date:  2018-03-23       Impact factor: 12.701

3.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors:  A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 4.  Towards individualized therapy for metastatic renal cell carcinoma.

Authors:  Ritesh R Kotecha; Robert J Motzer; Martin H Voss
Journal:  Nat Rev Clin Oncol       Date:  2019-10       Impact factor: 66.675

5.  Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA.

Authors:  Le Qu; Jin Ding; Cheng Chen; Zhen-Jie Wu; Bing Liu; Yi Gao; Wei Chen; Feng Liu; Wen Sun; Xiao-Feng Li; Xue Wang; Yue Wang; Zhen-Yu Xu; Li Gao; Qing Yang; Bin Xu; Yao-Ming Li; Zi-Yu Fang; Zhi-Peng Xu; Yi Bao; Deng-Shuang Wu; Xiong Miao; Hai-Yang Sun; Ying-Hao Sun; Hong-Yang Wang; Lin-Hui Wang
Journal:  Cancer Cell       Date:  2016-04-21       Impact factor: 31.743

6.  The expressions of CD133, ALDH1, and vasculogenic mimicry in osteosarcoma and their clinical significance.

Authors:  Zhengqi Bao; Zenong Cheng; Damin Chai
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

7.  Androgen receptor increases hematogenous metastasis yet decreases lymphatic metastasis of renal cell carcinoma.

Authors:  Qingbo Huang; Yin Sun; Xin Ma; Yu Gao; Xintao Li; Yuanjie Niu; Xu Zhang; Chawnshang Chang
Journal:  Nat Commun       Date:  2017-10-13       Impact factor: 14.919

8.  Androgen receptor regulates ASS1P3/miR-34a-5p/ASS1 signaling to promote renal cell carcinoma cell growth.

Authors:  Kefeng Wang; Yin Sun; Changcheng Guo; Tao Liu; Xiang Fei; Chawnshang Chang
Journal:  Cell Death Dis       Date:  2019-04-18       Impact factor: 8.469

9.  A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data.

Authors:  Hongjuan Zhao; John T Leppert; Donna M Peehl
Journal:  PLoS One       Date:  2016-01-27       Impact factor: 3.240

10.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.

Authors:  J Ferlay; M Colombet; I Soerjomataram; C Mathers; D M Parkin; M Piñeros; A Znaor; F Bray
Journal:  Int J Cancer       Date:  2018-12-06       Impact factor: 7.396

View more
  9 in total

1.  Orchestrated expression of vasculogenic mimicry and laminin-5γ2 is an independent prognostic marker in oral squamous cell carcinoma.

Authors:  Depanwita Saha; Debarpan Mitra; Neyaz Alam; Sagar Sen; Saunak Mitra Mustafi; Syamsundar Mandal; Biswanath Majumder; Nabendu Murmu
Journal:  Int J Exp Pathol       Date:  2022-02-16       Impact factor: 1.925

Review 2.  Nonsense-mediated RNA decay: an emerging modulator of malignancy.

Authors:  Kun Tan; Dwayne G Stupack; Miles F Wilkinson
Journal:  Nat Rev Cancer       Date:  2022-05-27       Impact factor: 69.800

Review 3.  Circulating microRNAs from the Molecular Mechanisms to Clinical Biomarkers: A Focus on the Clear Cell Renal Cell Carcinoma.

Authors:  Claudia Tito; Elena De Falco; Paolo Rosa; Alessia Iaiza; Francesco Fazi; Vincenzo Petrozza; Antonella Calogero
Journal:  Genes (Basel)       Date:  2021-07-28       Impact factor: 4.096

4.  A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients.

Authors:  Patrick Terrematte; Dhiego Souto Andrade; Josivan Justino; Beatriz Stransky; Daniel Sabino A de Araújo; Adrião D Dória Neto
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

5.  Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.

Authors:  Yue Li; Ruoyi Shen; Anqi Wang; Jian Zhao; Jieqi Zhou; Weijie Zhang; Ruochen Zhang; Jianjie Zhu; Zeyi Liu; Jian-An Huang
Journal:  Front Cell Dev Biol       Date:  2021-03-18

Review 6.  The role of ceRNA-mediated diagnosis and therapy in hepatocellular carcinoma.

Authors:  Yi Shi; Ji-Bin Liu; Jing Deng; Da-Zhi Zou; Jian-Jun Wu; Ya-Hong Cao; Jie Yin; Yu-Shui Ma; Fu Da; Wen Li
Journal:  Hereditas       Date:  2021-11-10       Impact factor: 3.271

Review 7.  LncRNAs in the Regulation of Genes and Signaling Pathways through miRNA-Mediated and Other Mechanisms in Clear Cell Renal Cell Carcinoma.

Authors:  Eleonora A Braga; Marina V Fridman; Elena A Filippova; Vitaly I Loginov; Irina V Pronina; Alexey M Burdennyy; Alexander V Karpukhin; Alexey A Dmitriev; Sergey G Morozov
Journal:  Int J Mol Sci       Date:  2021-10-17       Impact factor: 5.923

Review 8.  Interaction between Non-Coding RNAs and Androgen Receptor with an Especial Focus on Prostate Cancer.

Authors:  Mohammad Taheri; Tayyebeh Khoshbakht; Elena Jamali; Julia Kallenbach; Soudeh Ghafouri-Fard; Aria Baniahmad
Journal:  Cells       Date:  2021-11-16       Impact factor: 6.600

9.  The G3BP1-UPF1-Associated Long Non-Coding RNA CALA Regulates RNA Turnover in the Cytoplasm.

Authors:  Luisa Kirchhof; Youssef Fouani; Andrea Knau; Galip S Aslan; Andreas W Heumüller; Ilka Wittig; Michaela Müller-McNicoll; Stefanie Dimmeler; Nicolas Jaé
Journal:  Noncoding RNA       Date:  2022-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.